Identification of HIV-1 determinants for replication in vivo

被引:25
|
作者
Su, LS
Kaneshima, H
Bonyhadi, ML
Lee, R
Auten, J
Wolf, A
Du, B
Rabin, L
Hahn, BH
Terwilliger, E
McCune, JM
机构
[1] NEW ENGLAND DEACONESS HOSP, BOSTON, MA 02215 USA
[2] UNIV ALABAMA, DEPT HEMATOL & ONCOL, BIRMINGHAM, AL 35295 USA
[3] UNIV CALIF SAN FRANCISCO, GLADSTONE INST VIROL & IMMUNOL, SAN FRANCISCO, CA 94141 USA
[4] SYSTEMIX INC, HIV GRP, PALO ALTO, CA 94304 USA
关键词
D O I
10.1006/viro.1996.8338
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pathogenic organisms are frequently attenuated after long-term culture in vitro. The mechanisms of the attenuation process are not clear, but probably involve mutations of functions required for replication and pathogenicity in vivo. To identify these functions, a direct comparison must be made between attenuated genomes and those that remain pathogenic in vivo. In this study, we used the heterochimeric SCID-hu Thy/Liv mouse as an in vivo model to define human immunodeficiency virus type 1 (HIV-1) determinants which are uniquely required for replication in vivo. The Lai/IIIB isolate and its associated infectious molecular clones (e.g., HXB2) were found to infect T cell lines but failed to replicate in the SCID-hu Thy/Liv model. When a lab worker was accidentally infected by Lai/IIIB, however, HIV-1 was isolated only from infection of primary PBMC, and not from infection of T cell lines. We hypothesized that the lab worker was exposed to a heterogeneous viral stock which had been attenuated by passage in immortalized T cell lines. Either a rare family member from this stock was selected for in vivo replication or, alternatively, an attenuated genotype dominant in vitro may have reverted to become more infectious in vivo. To address this hypothesis, we have used the SCID-hu Thy/Liv model to study the replication of HXB2 and of HXB2 recombinant viruses with HIV-1 fragments isolated from the infected lab worker. HXB2 showed no or very low levels of replication in the Thy/Liv organ. Replacement of its subgenomic fragment encoding the envelope gene with a corresponding fragment from the lab worker isolate generated a recombinant virus (HXB2/LW) which replicated actively in SCID-hu mice. The NEF mutation in the HXB2 genome is still present in HXB2/LW. Thus, the LW sequences encode HIV-1 determinants which enhance HIV replication in vivo in a NEF-independent mechanism. The specific determinants have been mapped to the V1-V3 regions of the HIV-1 genome. Six unique mutations in the V3 loop region of HXB2/LW have been identified which contribute to the increased replication in vivo. (C) 1997 Academic Press
引用
收藏
页码:45 / 52
页数:8
相关论文
共 50 条
  • [31] Immune control of HIV-1 replication
    Walker, BD
    Rosenberg, ES
    Hay, CM
    Basgoz, N
    Yang, OO
    MECHANISMS OF LYMPHOCYTE ACTIVATION AND IMMUNE REGULATION VII: MOLECULAR DETERMINANTS OF MICROBIAL IMMUNITY, 1998, 452 : 159 - 167
  • [32] Elite Suppression of HIV-1 Replication
    Blankson, Joel N.
    Siliciano, Robert F.
    IMMUNITY, 2008, 29 (06) : 845 - 847
  • [33] Expression of HIV-1 integrase in CEM cells inhibits HIV-1 replication
    van Griensven, J
    Zhan, XJ
    Van Maele, B
    Pluymers, W
    Michiels, M
    De Clercq, E
    Cherepanov, P
    Debyser, Z
    JOURNAL OF GENE MEDICINE, 2004, 6 (03): : 268 - 277
  • [34] Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease
    Davis, David A.
    Brown, Cara A.
    Singer, Kathleen E.
    Wang, Victoria
    Kaufman, Joshua
    Stahl, Stephen J.
    Wingfield, Paul
    Maeda, Kenji
    Harada, Shigeyoshi
    Yoshimura, Kazuhisa
    Kosalaraksa, Pope
    Mitsuya, Hiroaki
    Yarchoan, Robert
    ANTIVIRAL RESEARCH, 2006, 72 (02) : 89 - 99
  • [35] HIV-1 dynamics in vivo
    Bursaux, E
    M S-MEDECINE SCIENCES, 1996, 12 (6-7): : 820 - 821
  • [36] Silencing HIV-1 in vivo
    Kirchhoff, Frank
    CELL, 2008, 134 (04) : 566 - 568
  • [37] HIV-1 dynamics in vivo
    Ho, D
    CHALLENGES IN MEDICINE: 100TH BIRTHDAY OF ERNST JUNG - PRIZES AND MEDALS AWARDED IN 1996, 1996, 8 : 7 - 8
  • [38] HIV-1 dynamics in vivo
    Ho, DD
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 1995, 9 (03): : 76 - 77
  • [39] Hypermutation of HIV-1 in vivo
    Denise Waldron
    Nature Reviews Genetics, 2015, 16 (11) : 626 - 626
  • [40] HIV-1 dynamics in vivo
    Ho, DD
    RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES, 1996, : 5 - 8